Johnson Bixby & Associates’s Amgen AMGN Stock Holding History

Johnson Bixby & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	+696	New	+$238K	0.03%	116
2025 Q2	–	Sell	-709	Closed	-$221K	–	124
2025 Q1	$221K	Buy	+709	New	+$209K	0.03%	106
2024 Q4	–	Sell	-709	Closed	-$228K	–	117
2024 Q3	$228K	Hold	709	–	–	0.03%	104
2024 Q2	$222K	Hold	709	–	–	0.04%	103
2024 Q1	$202K	Sell	709 -57	-7%	-$16.7K	0.04%	110
2023 Q4	$221K	Hold	766	–	–	0.04%	101
2023 Q3	$206K	Buy	+766	New	+$191K	0.04%	96
2023 Q2	–	Sell	-866	Closed	-$209K	–	94
2023 Q1	$209K	Hold	866	–	–	0.05%	94
2022 Q4	$227K	Sell	866 -130	-13%	-$34.8K	0.05%	94
2022 Q3	$224K	Hold	996	–	–	0.06%	90
2022 Q2	$242K	Hold	996	–	–	0.06%	89
2022 Q1	$241K	Hold	996	–	–	0.06%	81
2021 Q4	$224K	Hold	996	–	–	0.06%	80
2021 Q3	$212K	Sell	996 -100	-9%	-$23K	0.06%	76
2021 Q2	$249K	Sell	1,096 -50	-4%	-$12.3K	0.07%	71
2021 Q1	$285K	Hold	1,146	–	–	0.09%	63
2020 Q4	$263K	Buy	+1,146	New	+$264K	0.09%	64

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Johnson Bixby & Associates's AMGN Position: Q2 2026 in Review

Johnson Bixby & Associates opened a new position in Amgen (AMGN) in Q2 2026: 696 shares worth $252K. The stake represents 0.03% of the portfolio and ranks #116 among its holdings. This is a return to the name: Johnson Bixby & Associates previously reported a position in AMGN as recently as Q1 2025.

Johnson Bixby & Associates first reported a position in AMGN in Q4 2020 and has held it in 17 quarters since. The position peaked at $285K in Q1 2021. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Johnson Bixby & Associates held 696 shares of Amgen worth $252K as of Q2 2026.
Amgen was a new Johnson Bixby & Associates position in Q2 2026.
Amgen made up 0.03% of Johnson Bixby & Associates's portfolio in Q2 2026, its #116 holding.
Johnson Bixby & Associates first reported a position in Amgen in Q4 2020 and has held it in 17 quarters since.
Johnson Bixby & Associates's Amgen position peaked at $285K in Q1 2021.
1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Johnson Bixby & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.